COMPANY'S OPERATIONS (Tables)

12 Months Ended

Dec. 31, 2019

Summary of equity interest in the entities

% equity interest

Type of

Accounting

December 31,

Entity

Main activity

Country

investment

method

2019

2018

AGFA – Com. Adm. e Participações Ltda.

Holding

Brazil

Direct

Consolidated

100

Asapir Produção Florestal e Comércio Ltda. (1)

Eucalyptus cultivation

Brazil

Direct

Consolidated

100

CelluForce Inc.

Nanocrystalline pulp research and development

Canada

Direct

Fair value through other comprehensive income

8.3

Comercial e Agrícola Paineiras Ltda.

Lease of reforestation land

Brazil

Direct

Consolidated

100

Ensyn Corporation

Bio fuel research and development

United States of America

Direct

Equity

25.3

Eucalipto Holding S.A. (2)

Holding

Brazil

Direct

Consolidated

100

Facepa - Fábrica de Papel da Amazônia S.A.

Industrialization and commercialization of tissue paper

Brazil

Direct/Indirect

Consolidated

92.8

Fibria Celulose (USA) Inc.

Business office

United States of America

Direct

Consolidated

100

Fibria Terminal de Celulose de Santos SPE S.A.

Port operation

Brazil

Direct

Consolidated

100

Fibria Overseas Finance Ltd.

Financial fundraising

Cayman Island

Direct

Consolidated

100

Fibria Overseas Holding KFT. (3)

Consolidated

100

Fibria Terminais Portuários S.A.

Port operation

Brazil

Direct

Consolidated

100

FuturaGene AgriDev Xinjiang Company Ltd.

Biotechnology research and development

China

Indirect

Consolidated

100

FuturaGene Biotechnology Shangai Company Ltd.

Biotechnology research and development

China

Indirect

Consolidated

100

FuturaGene Brasil Tecnologia Ltda.

Biotechnology research and development

Brazil

Direct/Indirect

Consolidated

100

FuturaGene Delaware Inc.

Biotechnology research and development

United States of America

Indirect

Consolidated

100

FuturaGene Hong Kong Ltd.

Biotechnology research and development

Hong Kong

Indirect

Consolidated

100

FuturaGene Inc.

Biotechnology research and development

United States of America

Indirect

Consolidated

100

FuturaGene Israel Ltd.

Biotechnology research and development

Israel

Indirect

Consolidated

100

FuturaGene Ltd.

Biotechnology research and development

England

Indirect

Consolidated

100

F&E Tecnologia do Brasil S.A.

Biofuel production, except alcohol

Brazil

Indirect

Consolidated

F&E Tecnologies LLC

Biofuel production, except alcohol

United States of America

Direct

Equity

Gansu FuturaGene Biotech Co. Ltd.

Biotechnology research and development

China

Indirect

Consolidated

100

Ibema Companhia Brasileira de Papel

Industrialization and commercialization of paperboard

Brazil

Direct

Joint venture

49.9

Itacel - Terminal de Celulose de Itaqui S.A.

Port operation

Brazil

Indirect

Consolidated

100

Maxcel Empreendimentos e Participações S.A.

Holding

Brazil

Direct

Consolidated

100

Mucuri Energética S.A.

Power generation and distribution

Brazil

Direct

Consolidated

100

Ondurman Empreendimentos Imobiliários Ltda.

Lease of reforestation land

Brazil

Direct/Indirect

Consolidated

100

Paineiras Logística e Transporte Ltda.

Road freight transport

Brazil

Direct /Indirect

Consolidated

100

Portocel - Terminal Espec. Barra do Riacho S.A.

Port operation

Brazil

Direct

Consolidated

Projetos Especiais e Investimentos Ltda.

Commercialization of equipment and parts

Brazil

Direct

Consolidated

100

Rio Verde Participações e Propriedades Rurais S.A. (3)

Forest assets

Brazil

Indirect

Consolidated

100

Spinnova Oy

Research and development of sustainable raw materials (wood) for the textile industry

Finland

Direct

Equity

24.06

Stenfar S.A. Indl. Coml. Imp. Y. Exp.

Commercialization of computer paper and materials

Argentine

Direct /Indirect

Consolidated

100

Sun Paper and Board Limited (4)

Shared expenses

Consolidated

100

Suzano Áustria GmbH

Business office

Austria

Direct

Consolidated

100

Suzano Canada Inc. (5)

Lignin research and development

Canada

Direct

Consolidated

100

Suzano International Trade GmbH (6)

Business office

Austria

Direct

Consolidated

100

Suzano Luxembourg (7)

Financial fundraising

Luxembourg

Direct

Consolidated

100

Suzano Participações do Brasil Ltda (8)

Holding

Brazil

Direct

Consolidated

100

Suzano Pulp and Paper America Inc.

Business office

United States of America

Direct

Consolidated

100

Suzano Pulp and Paper Europe S.A.

Business office

Switzerland

Direct

Consolidated

100

Suzano Trading Ltd.

Business office

Cayman Island

Direct

Consolidated

100

Suzano Trading International KFT (9)

Business office

Hungary

Direct

Consolidated

100

Veracel Celulose S.A. (10)

Industrialization, commercialization and exportation of pulp

Brazil

Joint operation

Consolidated

¹⁾

The full control was acquired arising from the business combination with Fibria.

²⁾

Company merged on January 2, 2019, as mentioned in note 1.2.1.1.

³⁾

Company established as a result of corporate restructuring on December 12, 2019.

⁴⁾

Company dissolution on June 2, 2019.

⁵⁾

Corporate name changed on September 30, 2019, former Fibria Innovations Inc.

⁶⁾

Corporate name changed on August 28, 2019, former Fibria International Trade GmbH.

⁷⁾

Company dissolution on September 17, 2019.

⁸⁾

Corporate name changed on December 06, 2019, former F&E Participações do Brasil Ltda.

⁹⁾

Corporate name changed on August 9, 2019, former Fibria Trading International.

¹⁰⁾

Joint operation with Stora Enso, a company located in Amsterdan.

Summary of final purchase price allocation

The following table summarizes the final purchase price allocation based on the appraisal report prepared by an independent and specialized entity:


Cash consideration	27,797,441
Issuance of shares by Suzano	9,438,413
Total consideration	37,235,854

Book value of Fibria's shareholders' equity	14,149,004
Write-off of the book value of existing goodwill, net of the deferred income taxes	(3,495,077)
Mandatory minimum dividends (eliminated from the balance sheet at the date of acquisition)	724,829
Book value of Fibria's shareholders' equity, net of goodwill	11,378,756

Fair value adjustment on business combination with Fibria (assets and liabilities):
Inventories	2,178,903	(1)
Property, plant and equipment	9,362,315	(2)
Customer relationship	9,030,779	(3)
Port assets	749,060	(4)
Contingent liabilities	(2,970,546)	(5)
Loans and financing	(59,921)	(6)
Taxes recoverable	(235,843)	(7)
Other assets and liabilities, net	451,624	(8)
Deferred taxes, net	(546,324)	(9)
Total impact of fair value	17,960,047
Goodwill on the expectation of future profitability	7,897,051	(10)

¹⁾

Measured considering the balance of finished products based on selling price, net of selling expenses and an accepted margin based on the results achieved in 2018.

²⁾

Determined based on the analysis of market data on comparable transactions and cost quantification, based on the estimate of replacement or replacement value of the assets.

³⁾

In order to determine the fair value adjustment in the customer portfolio, the income approach and the method were used to measure the present value of the income that will be generated during the remaining useful life of the asset. Considering the 5-year history of Fibria's sales data and the churn rate that measures customer satisfaction and customer permanence in the portfolio, the adjustment was measured using estimated discounted cash flows. The churn rate and the discounted cash flows were considered as significant assumptions to determine the fair value of the customer portfolio.

⁴⁾

Fibria has concession contracts and port assets to assist in port operations in Brazil. For fair value measurement of these assets was considered the income approach, the Multi Period Excess Earnings Method (“MPEEM”) that measures the present value of the income that will be generated during the remaining useful life of the asset and method of direct cost differential.

⁵⁾

In the business combination, for the contingencies fair value measurement, whose chances of loss were classified as possible and remote, Fibria's Management and its external and independent advisors were considered for their fair values, whose amounts were measured based on the analyzes of Company’s external lawyers. Thus, the estimated and assumptions with respect to the probability of loss of the possible and remote lawsuit, for the fair value calculation of contingent liabilities assumed were considered as significant assumptions to determine the fair value of the contingent liabilities.

⁶⁾

The adjustment to fair value of loans and financing was measured based on the fair value of the Bonds, based on the quotation of the security in the secondary market, and the adjustment to present value considering the market rate at the base date on December 31, 2018.

⁷⁾

For the measurement of the fair value of the taxes to be recovered, the amount to be recovered, discounted to the present value considering the expected Selic rate for the tax period, was considered.

⁸⁾

In other net assets and liabilities, including supply contracts, accounts receivable and advances to suppliers, the income evaluation methodology, the present value and the direct cost differential were used.

⁹⁾

Deferred asset on income tax on fair value adjustments of assets of Veracel and Portocel. For the remaining fair value, we did not recognize deferred liability on income taxes liabilities due to Fibria’s Legal Merger in April 2019.

¹⁰⁾

Goodwill is attributable to the strong market position and expected future profitability of Fibria in negotiations in the eucalyptus pulp market.

Summary of main items balance sheet

The following table summarizes, the main items balance sheet of Fibria as of March 31, 2019.


ASSETS		LIABILITIES
CURRENT		CURRENT
Cash and cash equivalents	29,086	Loans and financing	816,180
Marketable securities	2,734,027	Lease liabilities	420,241
Derivative financial instruments	256,675	Trade accounts payable	955,210
Trade accounts receivable	3,572,059	Derivative financial instruments	254,444
Inventories	1,714,560	Payroll and charges	104,246
Recoverable taxes	768,439	Taxes payable	36,057
Other assets	161,238	Related parties	1,179,254
	9,236,084	Dividends payable	4,015
		Other liabilities	946,099
			4,715,746
NON CURRENT		NON CURRENT
Marketable securities	175,559	Loans and financing	8,139,390
Derivative financial instruments	723,084	Derivative financial instruments	678,833
Recoverable taxes	546,234	Lease liabilities	1,972,531
Deferred taxes	1,364,363	Related parties	16,305,560
Advances to suppliers	696,767	Employee benefits	144,557
Judicial deposits	190,533	Provision for judicial liabilities	190,698
Other assets	100,877	Other liabilities	175,934
Biological assets	4,355,102		27,607,503
Investments	9,481,900
Property, plant and equipment	14,633,114	TOTAL LIABILITIES	32,323,249
Right of use	2,301,427
Intangible assets	118,920	Equity	11,600,715
	34,687,880
		TOTAL EQUITY AND LIABILITIES	43,923,964
TOTAL ASSETS	43,923,964